Halozyme Therapeutics shares owned by Neo Ivy Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Neo Ivy Capital Management
from 13F filings
Historical chart of Neo Ivy Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Neo Ivy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Neo Ivy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $395k | 5.4k | 73.34 |
| 2025-06-30 | $1.3M | 24k | 52.02 |
| 2023-12-31 | $207k | 5.6k | 36.95 |
| 2021-09-30 | $496k | 19k | 26.82 |
| 2021-06-30 | $59k | 1.3k | 45.70 |
| 2021-03-31 | $124k | 3.0k | 41.81 |
| 2020-12-31 | $340k | 8.0k | 42.76 |
| 2020-09-30 | $233k | 8.9k | 26.19 |
| 2020-06-30 | $496k | 19k | 26.82 |
| 2020-03-31 | $29k | 1.6k | 18.22 |
| 2019-09-30 | $381k | 23k | 16.50 |
| 2019-06-30 | $1.4M | 84k | 17.19 |
More positions owned by Neo Ivy Capital Management
View all positions for Neo Ivy Capital Management